Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality
and the only cancer for which the incidence and mortality are on the rise. Sensitive and …

Background: Hepatocellular carcinoma (HCC) significantly contributes to the global burden
of cancer. Liver cancer is the third most frequent cause of cancer-related death, with HCC …

Liver cancer ranks fifth in incidence and fourth in overall cancer-related mortality, with
approximately 854,000 new cases and 810,000 deaths per year worldwide. Hepatocellular …

Staging systems aim to stratify patients into groups with similar prognoses. As such, these
staging systems may serve to guide choice of therapy, aid in patient counseling, allow …

The treatment planning for patients with hepatocellular carcinoma (HCC) relies
predominantly on tumor burden, clinical performance, and liver function test results. Curative …

Hepatocellular carcinoma (HCC) is a prevalent primary liver cancer, representing over 90%
of cases globally and ranking as the third leading cause of cancer-related death. This article …

The therapeutic approach to treating patients with hepatocellular carcinoma (HCC) has
changed radically over the past few decades and continues to evolve as the biology and …

Hepatocellular carcinoma (HCC) is an aggressive tumor that frequently occurs in the setting
of chronic liver disease and cirrhosis (see" Epidemiology and risk factors for hepatocellular …

The field of hepatocellular carcinoma (HCC) has experienced major changes during the last
few years. Until very recently, HCC was regarded as a neoplasm with marginal incidence in …

Multiple hepatocellular carcinoma (HCC) staging systems have been proposed and used
clinically over time. These may consider clinical, pathological, radiological, or treatment …